{
  "id": 1897026,
  "title": "Rakovina Therapeutics Announces Results from 2026 Annual General Meeting",
  "url": "https://urgent.news/2026/08/19/rakovina-therapeutics-announces-results-from-2026-annual-general",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T08:03:40.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/rakovina-therapeutics-announces-results-from-2026-annual-general-meeting"
  },
  "original_language": "en",
  "account": null,
  "summary": "VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce the results of voting at its 2026 annual general meeting of shareholders held on August 18, 2026, in Toronto, Ontario (the “Meeting”). All five […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}